The rally in emerging markets equities is more than 23 months old, with stocks up more than 75% since a trough in early 2016. Is the rebound getting long in the tooth? It could just be getting started. An expanding global economy, strengthening currencies and robust demand for technology-related components all bode well for emerging markets. A synchronized global recovery is an ideal environment for emerging markets, similar to the period that lasted from 2003 to 2007.
Amid the ongoing rebound, overall valuations are still attractive from a historical basis and compared to developed markets. For instance, China, Taiwan and Brazil all trade around 13 times projected earnings over the next year, compared with 17 times estimated earnings for the MSCI World Index. Company cash flows are also increasing, which could lead to higher earnings revisions. Corporate profits are forecast to climb 13% in 2018, and historically rising profits have been good for share prices.
Investments are not FDIC-insured, nor are they deposits of or guaranteed by a bank or any other entity, so they may lose value.
Investors should carefully consider investment objectives, risks, charges and expenses. This and other important information is contained in the fund prospectuses and summary prospectuses, which can be obtained from a financial professional and should be read carefully before investing.
Information provided on this website is intended for use by financial advisors with persons who are eligible to purchase U.S.-registered mutual funds.
Securities offered through American Funds Distributors, Inc.
Content contained herein is not intended to serve as impartial investment or fiduciary advice. The content has been developed by Capital Group, which receives fees for managing, distributing and/or servicing its investments.
Statements attributed to an individual represent the opinions of that individual as of the date published and do not necessarily reflect the opinions of Capital Group or its affiliates. This information is intended to highlight issues and should not be considered advice, an endorsement or a recommendation.